Showing 1 - 7 results of 7 for search 'Ivana Puliafito', query time: 1.50s Refine Results
  1. 1
    Volumetric Modulated Arc Therapy Capabilities for Treating Lower-Extremity Skin Affected by Several Merkel Cell Carcinoma Nodules: When Technological Advances Effectively Achieve the Palliative Therapeutic Goal while Minimising the Risk of Potential Toxicities

    Volumetric Modulated Arc Therapy Capabilities for Treating Lower-Extremity Skin Affected by Several Merkel Cell Carcinoma Nodules: When Technological Advances Effectively Achieve t... by Gianluca Ferini, Vito Valenti, Ivana Puliafito, Salvatore Ivan Illari, Valentina Anna Marchese, Giuseppina Rita Borzì

    Published 2021-12-01
    Get full text
    Article
  2. 2
    Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects

    Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects by Ivana Puliafito, Francesca Esposito, Angela Prestifilippo, Stefania Marchisotta, Dorotea Sciacca, Maria Paola Vitale, Dario Giuffrida

    Published 2022-07-01
    Get full text
    Article
  3. 3
    Metabolic complete tumor response in a patient with mutant non-small cell lung cancer treated with a reduced dose of afatinib

    Metabolic complete tumor response in a patient with mutant non-small cell lung cancer treated with a reduced dose of afatinib by Ivana Puliafito, Francesca Esposito, Gabriele Raciti, Paolo Giuffrida, Claudia Caltavuturo, Cristina Colarossi, Stefania Munao, Dorotea Sciacca, Dario Giuffrida

    Published 2022-03-01
    Get full text
    Article
  4. 4
    NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression

    NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression by Sarah Adriana Scuderi, Giovanna Casili, Rossella Basilotta, Marika Lanza, Alessia Filippone, Gabriele Raciti, Ivana Puliafito, Lorenzo Colarossi, Emanuela Esposito, Irene Paterniti

    Published 2021-10-01
    Get full text
    Article
  5. 5
    TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma

    TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma by Michela Campolo, Marika Lanza, Giovanna Casili, Irene Paterniti, Alessia Filippone, Maria Caffo, Salvatore M. Cardali, Ivana Puliafito, Cristina Colarossi, Gabriele Raciti, Salvatore Cuzzocrea, Emanuela Esposito

    Published 2020-12-01
    Get full text
    Article
  6. 6
    Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis

    Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis by Ivana Puliafito, Federico Chillari, Alessandro Russo, Ornella Cantale, Dorotea Sciacca, Luigi Castorina, Cristina Colarossi, Tindara Franchina, Maria Paola Vitale, Giuseppina Rosaria Rita Ricciardi, Vincenzo Adamo, Francesca Esposito, Dario Giuffrida

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort

    Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort by Francesco Panzuto, Elisa Andrini, Giuseppe Lamberti, Sara Pusceddu, Maria Rinzivillo, Fabio Gelsomino, Alessandra Raimondi, Alberto Bongiovanni, Maria Vittoria Davì, Mauro Cives, Maria Pia Brizzi, Irene Persano, Maria Chiara Zatelli, Ivana Puliafito, Salvatore Tafuto, Davide Campana

    Published 2024-04-01
    Get full text
    Article

Search Tools: